Indian pharma firms need to increase research and development investment: Report Ruby Khatun Khatun18 July 2017 10:00 AM ISTNew Delhi: Indian pharma firms need to increase investments in research and development and quality of manufacturing to comply with global regulatory...
Cipla looks out for marketing tie-up with Novartis Ruby Khatun Khatun18 July 2017 9:53 AM ISTMUMBAI: Cipla, and Novartis are looking at the possibilities to jointly market asthma drug Xolair (omalizumab) an injectable prescription medicine...
Janssen Wins FDA Approval of Tremfya (Guselkumab) for the treatment of Plaque Psoriasis Ruby Khatun Khatun18 July 2017 9:53 AM ISTHorsham, PA: Janssen Biotech, Inc. (Janssen) announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA™ (guselkumab) for the...
Novartis stocks drug cabinet with Big-3 arthritis blockbusters Ruby Khatun Khatun17 July 2017 9:50 AM ISTZURICH: Switzerland's Novartis is stocking up cheaper versions of the world's top-selling arthritis medicines, hoping a broad portfolio gives it an...
Zydus Cadila gets USFDA nod for sclerosis drug Ruby Khatun Khatun17 July 2017 9:40 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received tentative nod from the US health regulator to market Fingolimod capsules used for treatment of...
Abbott, Bigfoot Biomedical Announce Collaboration to Develop Breakthrough Diabetes Technologies Ruby Khatun Khatun17 July 2017 9:35 AM IST Abbott and Bigfoot Biomedical announced that the companies have entered into an agreement to develop and commercialize diabetes management systems,...
CDSCO urges Pharma Companies for urgent release of stocks after Relabeling Ruby Khatun Khatun17 July 2017 9:32 AM ISTThere has been a reported shortage of essential medicines after implementation of GST on 1st July 2017. Responding to the news, Central Drugs Standard...
Nutraceuticals market may grow to 10 billion dollar by 2022: Assocham Ruby Khatun Khatun17 July 2017 9:07 AM ISTMumbai: Indian nutraceuticals market is expected to grow at a compounded annual growth rate of 21 per cent and reach USD 10 billion by 2022 from USD 4...
CDSCO calls Stakeholder meeting for feedback on Sugam, check out details Ruby Khatun Khatun16 July 2017 12:06 PM ISTThrough a recent notice CDSCO have invited stakeholders for meeting regarding the feedback on new modules of SUGAM portal which will be held at FDA...
Alembic Pharma opens Rs 300 crore anti-cancer drug unit in Gujarat Ruby Khatun Khatun16 July 2017 10:03 AM ISTVADODARA: Drug firm Alembic Pharmaceuticals Ltd (APL) entered into oncology segment by inaugurating a Rs 300 crore anti-cancer drug facility at Halol...
Amgen gets FDA approval for BLINCYTO (blinatumomab) to treat Acute Lymphoblastic Leukemia Ruby Khatun Khatun16 July 2017 9:40 AM ISTTHOUSAND OAKS, Calif.: Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...
FDA Advisory Committee Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab Ruby Khatun Khatun16 July 2017 9:10 AM ISTHERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA)...
